The biotech sector in Poland has been expanding rapidly over the past decade. Traditionally, the country’s pharmaceutical industry focused on generic drug production, but in recent years, biotech companies in Poland have shifted towards biologics, precision medicine, and advanced drug development.

This transformation is driven by strong academic research, government grants, and venture capital investments, allowing Poland to position itself as an emerging hub for biomedical startups. Many Poland biotech companies are now making progress in areas such as oncology, microbiome-based therapies, regenerative medicine, and AI-driven drug discovery.

Here, we highlight 20 biotech companies in Poland that are making a significant impact in healthcare, diagnostics, and therapeutics.

‍

PROTEON PHARMACEUTICALS

• CEO: Jaroslaw Dastych
• Founded: 2005
• Headquarters: Łódź, Poland

Proteon Pharmaceuticals is a biotech startup Poland focused on developing bacteriophage-based therapies that target harmful bacteria while preserving microbiome balance. Its solutions help reduce antibiotic overuse in animal farming and human health, contributing to efforts against antimicrobial resistance (AMR). The company has received investments from Montis Capital Group and Nutreco and is considered one of the leading biotech companies in Poland working in microbiome research.

‍

MABION

• CEO: Krzysztof Kaczmarczyk
• Founded: 2007
• Headquarters: Konstantynów Łódzki, Poland

Mabion specializes in biosimilar antibody development and biomanufacturing. Its lead product is a biosimilar version of rituximab, a monoclonal antibody used to treat blood cancers and autoimmune disorders. The company is advancing through Phase 3 clinical trials. Additionally, Mabion has partnered with Novavax to support vaccine antigen production for international markets. As one of the top biotech Poland firms, it continues to play a role in drug manufacturing and commercialization.

‍

MOLECURE

• CEO: Marcin Jan Szumowski
• Founded: 2012
• Headquarters: Warsaw, Poland

Molecure (formerly OncoArendi Therapeutics) is a biotech startup Poland developing small-molecule drugs for oncology and inflammatory diseases. The company is pioneering research into RNA-modifying enzymes, an emerging field in drug discovery. Molecure has secured funding from Michał Sołowow and New Europe Ventures, LLC and remains a key player among biomedical startups focused on first-in-class therapeutics.

‍

RYVU

• CEO: Pawel Przewiezlikowski
• Founded: 2007
• Headquarters: Kraków, Poland

Ryvu Therapeutics develops targeted small-molecule therapies for cancer, with a focus on hematological malignancies, solid tumors, and immuno-oncology applications. The company’s research aims to create more effective and safer alternatives to existing cancer treatments. Ryvu has received financial backing from the European Investment Bank and the National Center for Research & Development and remains one of the leading Poland biotech companies advancing oncology research.

‍

SCOPE FLUIDICS

• CEO: Piotr Garstecki
• Founded: 2010
• Headquarters: Warsaw, Poland

Scope Fluidics is a biotech Poland company developing microfluidic-based diagnostic systems. Its solutions focus on point-of-care testing for infectious diseases and antimicrobial resistance, allowing faster and more accurate diagnostics. The company has received funding from the National Center for Research & Development and the European Investment Bank, reinforcing its role in the medical diagnostics industry.

‍

‍

NAPIFERYN BIOTECH

• CEO: Magdalena Kozłowska
• Founded: 2014
• Headquarters: Łódź, Poland

NapiFeryn Biotech is a biomedical startup focused on plant-based protein production. The company has patented a method to extract protein isolates from rapeseed, offering a sustainable alternative to traditional protein sources. With grants from EIT Food and EASME, NapiFeryn continues to expand its technology to support the alternative protein industry.

‍

BOWIL BIOTECH

• Founded: 2006
• Headquarters: Władysławowo, Poland

Bowil Biotech specializes in biocellulose production through bacterial fermentation. Its primary applications include medical and cosmetic products, such as wound dressings and biocellulose face masks. While Bowil Biotech remains focused on biomedical applications, its potential industrial uses for biocellulose are still in research and development.

‍

PURE BIOLOGICS

• CEO: Filip Jelen
• Founded: 2010
• Headquarters: Wrocław, Poland

Pure Biologics develops biologic drugs using antibodies and aptamers for autoimmune diseases, rare neurological disorders, and cancer. The company leverages advanced selection platforms to accelerate drug discovery. Funded by the National Center for Research & Development, Pure Biologics is regarded as one of the key biomedical startups in Poland focused on precision medicine.

‍

NANO VELOS

• Founded: 2013
• Headquarters: Warsaw, Poland

NanoVelos is developing nanoparticle-based drug delivery systems for cancer therapy. Its dextran-based nanoparticles are designed to improve targeted drug release, enhancing treatment efficacy while reducing side effects. Although NanoVelos is still in preclinical research, its innovations in nanotechnology for medicine place it among Poland's promising biomedical startups.

‍

POLTREG

• CEO: Piotr Trzonkowski
• Founded: 2015
• Headquarters: Gdańsk, Poland

PolTREG is a biotech startup Poland developing T-regulatory (TREG) cell therapies for autoimmune diseases. It focuses on conditions such as Type 1 Diabetes and Multiple Sclerosis, aiming to offer long-term solutions through cell-based immunotherapies. With funding from EASME and INNOventure, PolTREG is among the most advanced cell therapy companies in Poland, working on clinical-stage treatments.

‍

‍

ARDIGEN

• CEO: Janusz Homa
• Founded: 2015
• Headquarters: Kraków, Poland

Ardigen is a biotech Poland company integrating AI and bioinformatics to improve precision medicine and drug discovery. It develops computational models for cancer immunotherapy, microbiome research, and digital pathology.Ardigen collaborates with global pharmaceutical companies, helping accelerate biologics discovery using machine learning and multi-omics data analysis. With its AI-driven platforms, it is one of the leading biotech companies in Poland shaping the future of data-driven drug development.

‍

INPHARMICA

• Chairman: Szczepan Adamski
• Founded: 2015
• Headquarters: Warsaw, Poland

Inpharmica provides clinical trial management and pharmacovigilance services to pharmaceutical companies. It specializes in monitoring drug side effects, particularly analgesics and anti-inflammatory medications. The company helps ensure drug safety and regulatory compliance, making it a key player among biomedical startups focused on clinical research and patient safety analytics.

‍

SELVITA

• CEO: Bogusław Sieczkowski
• Founded: 2007
• Headquarters: Kraków, Poland

Selvita is a contract research organization (CRO) offering drug discovery and preclinical research services to pharmaceutical and biotech companies. It specializes in medicinal chemistry, toxicology studies, and early-stage drug development. In 2014, Selvita acquired BioCentrum, expanding its biopharmaceutical research capabilities. As one of the largest biotech Poland CROs, it supports international pharmaceutical firms in bringing novel therapeutics to market.

‍

HIPROMINE

• CEO: Damian Józefiak
• Founded: 2015
• Headquarters: Poznań, Poland

HiProMine focuses on alternative protein sources using insect-based bioconversion technology. The company breeds insects to produce sustainable protein meal and oil, which are used in animal feed, aquaculture, and pet food. By turning organic waste into valuable protein, HiProMine is a leader among biotech companies in Poland developing environmentally friendly solutions for global food security.

‍

INTO DNA

• CEO: Magda Kordon-Kiszala
• Founded: 2017
• Headquarters: Kraków, Poland

IntoDNA develops high-sensitivity DNA damage detection tools for cancer research and genotoxicity testing. Its proprietary STRIDE technology provides single-lesion resolution, making it valuable for studying DNA repair mechanisms and evaluating drug toxicity. Used by pharmaceutical firms and academic researchers, IntoDNA is among the biomedical startups improving genetic testing and precision diagnostics.

‍

‍

GENEGOGGLE

• CEO: Jakub Mieczkowski
• Founded: 2018
• Headquarters: Warsaw, Poland

Genegoggle applies AI-powered genomic analysis to personalized medicine and drug discovery. It integrates multi-omics data to identify disease biomarkers and optimize treatment approaches. Supported by Illumina Accelerator, Genegoggle is one of the emerging biotech Poland startups using computational genomics to advance precision healthcare.

‍

DEBN

• CEO: Marcin Sieczkowski
• Founded: 2017
• Headquarters: Gdańsk, Poland

DEBN is developing an antibiotic-coated biopsy needle to reduce infection risk in prostate biopsies. The device delivers localized antibiotics, improving patient safety and clinical outcomes. Backed by MassChallenge and Alfabeat, DEBN is among the biomedical startups innovating in medical device technology for urological procedures.

‍

BIOTON

• CEO: Michał Deptuch
• Founded: 1989
• Headquarters: Warsaw, Poland

Bioton is a publicly listed biotech company specializing in diabetes treatments. It produces recombinant human insulin and oral antidiabetic medications such as metformin and glimepiride. With global distribution and a focus on biopharmaceutical manufacturing, Bioton remains a leader among Poland biotech companies in diabetes care.

‍

CELON PHARMA

• CEO: Dr. Maciej Wieczorek
• Founded: 2002
• Headquarters: Kiełpin, Poland

Celon Pharma develops pharmaceuticals for neurological disorders, oncology, and respiratory diseases. It has clinical-stage drug candidates for schizophrenia, depression, and lung cancer, along with inhalation products for asthma and COPD. As one of the established biotech companies in Poland, Celon Pharma continues to expand its drug development pipeline for chronic and rare diseases.

‍

CAPTOR THERAPEUTICS

• CEO: Tom Shepherd
• Founded: 2017
• Headquarters: Wrocław, Poland

Captor Therapeutics specializes in targeted protein degradation therapies for cancer and autoimmune diseases. The company’s research focuses on developing drugs that selectively degrade disease-causing proteins.By working on novel treatment mechanisms, Captor Therapeutics is among the biotech Poland startups advancing next-generation therapeutics.

‍

Conclusion

Poland’s biotech industry has grown significantly, with a diverse range of startups and scaleups making advances in drug discovery, diagnostics, personalized medicine, and sustainable biotechnology. As Poland biotech companies continue to gain global recognition and investment, the country is solidifying its position as a rising hub for biotechnology innovation in Europe.

With support from platforms like Scispot, these biomedical startups can accelerate research, streamline operations, and develop groundbreaking therapies.

Poland’s biotech future looks promising, and the next few years will be crucial in shaping its global impact.